Stifel Initiates Coverage On Soleno Therapeutics With Buy Rating, Announces Price Target of $63
Stifel Initiates Coverage On Soleno Therapeutics With Buy Rating, Announces Price Target of $63
Stifel以买入评级启动对Soleno Therapeutics的报道，宣布目标股价为63美元
Stifel analyst Dae Gon Ha initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Buy rating and announces Price Target of $63.
Stifel分析师Dae Gon Ha以买入评级启动了对Soleno Therapeutics（纳斯达克股票代码：SLNO）的报道，并宣布目标股价为63美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。